Noria Therapeutics

Noria Therapeutics is a specialized biopharmaceutical company focused on developing treatments to address unmet clinical needs in reproductive medicine. Noria’s lead compound, NT100, is a novel biologic that mimics a protein naturally produced in the female reproductive tract. The mechanism of action of NT100 may enhance embryo implantation and support pregnancy maintenance by optimizing maternal-fetal immune tolerance.